ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BYOT Byotrol Plc

0.125
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.125 0.05 0.20 0.125 0.125 0.13 4,085,813 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.59M -1.69M -0.0037 -0.32 544.67k
Byotrol Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker BYOT. The last closing price for Byotrol was 0.13p. Over the last year, Byotrol shares have traded in a share price range of 0.075p to 2.60p.

Byotrol currently has 453,890,405 shares in issue. The market capitalisation of Byotrol is £544,668 . Byotrol has a price to earnings ratio (PE ratio) of -0.32.

Byotrol Share Discussion Threads

Showing 8751 to 8774 of 16375 messages
Chat Pages: Latest  355  354  353  352  351  350  349  348  347  346  345  344  Older
DateSubjectAuthorDiscuss
24/3/2020
15:22
Sick hasnt yet mentioned the lost opportunity in 1918 after spanish flu they got no business
wisecat2
24/3/2020
14:46
He clearly can't read and thinks he knows more than the nomad if he thinks this deal was already announced!The Agreement has a duration of 10 years and will be exclusive in hospitals in the UK and Ireland and non-exclusive elsewhere. Under the terms of the Agreement, Tristel will pay to Byotrol a combination of product supply payments, royalties and fees, based on success but with meaningful minimum guarantee payments to Byotrol each year.
slicethepie
24/3/2020
14:00
Boring and desperate. Close your short you have lost
wisecat2
24/3/2020
12:49
Cumnor

"It is the IP, the huge, strategic, tie up with a great company like Tristel"


The Tristel deal isn't new, it was announced in the AR months ago, so was already in the price...
It was, however, late to launch...


" One such transaction has been completed post year
end with Tristel plc, for a surface sanitising product that combines their best-in-class chlorine dioxide chemistry, with our long-lasting germ-killing technology; we expect this product to be launched in late 2019. "

sikhthetech
24/3/2020
12:43
Getting tight to buy again folks!
1kiwi
24/3/2020
12:18
Current sales (although if you look at RNS words like 'substantial' and 'orders not yet processed' should give a clue)are irrelevant to the SP, as we all know. It is the IP, the huge, strategic, tie up with a great company like Tristel, over 10 times BYOT's size' and the potential for several new deals in Europe, Asia and the US, esp now they will see Tristel on board, which will drive the price. And, of course, coronavirus has raised BYOT's profile substantially.
cumnor
24/3/2020
11:55
Some decent delayed buy trades in there.
loafofbread
24/3/2020
11:08
Only disinfectant offering 24hr protection with FDA approvalWhy would any hospital/commercial org use anything else with viruses like CV19
apatel21
24/3/2020
11:06
What price when a US deal is announced
apatel21
24/3/2020
10:35
Emerald,

"is approx 4 months before the peak"

They announced they have orders of £1.7m to end of June.
End of June is 3 months away, so they are already covered for 3 of those 4 months you mentioned.

Read the TU.

sikhthetech
24/3/2020
10:27
You are encouraging him with the replies. Ignore or just filter,
arcadian
24/3/2020
10:23
Yep - or put another way - i am still not persuaded that the best time to sell shares of a company involved with sanitising and cleanliness, is approx 4 months before the peak of the worst virus outbreak in the last 90 years. Anybody who does so - looks a bit desperate and silly.
emeraldzebra
24/3/2020
10:07
Sikh-you come across as a rather pitiful individual whose life is obsessed with deramping company shares you don't own. Nothing else in the world, or no other companies, considering the bargains around, on which you could turn your attention,
cumnor
24/3/2020
09:33
Filters are all the rage and are needed especially here.
arcadian
24/3/2020
09:31
Have a look at their sales after swine flu..

Sales increased from £0.38m to £1.99m. Similar to today.

They then had placings following the swine flu..



Also what happened to all those global partnerships following the Swine pandamic.




"The significant increase in sales is in part due to the concern regarding swine flu; however it can also be attributed to a greater appreciation of the qualities, efficacy and broad applications of Byotrol. "
"We remain confident of the prospects for Byotrol "

Distributors & Parners


" Healthcare through our relationship with Synergy Health plc in Europe and through distributors in the US
* Food and beverage, both through distributors and direct sales
* Consumer products through our joint venture, Byotrol Consumer Products Ltd. "

Revenues & Cash - placings

"with revenues increasing to GBP1,995,375 from GBP387,852 in the same period last year, albeit that some of the increase has related to concerns about swine flu."
"cash equivalents and receivables of GBP3,527,232 (2008:GBP1,537,820), partly as a result of the fund raising undertaken in Autumn 2008. "









yet, despite the huge increase in sales, they still had placings after Swine Flu outbreak...


29-08-15 .. £1.4m
25-06-14 .. £1.25m
25-06-13 .. £0.50m
21-10-11 .. £2.46m

sikhthetech
24/3/2020
09:24
Piedro

You said it "has been" We are in a different world

arcadian
24/3/2020
09:24
You have a SIKH who is neck deep with his short position on this thread who has been deramping, has been proven wrong yet again by yesterday's TU, bcz he has a huge vested interest in seeing the shareprice collapse - and he is not shy at underplaying and lying about the huge demand created by covid19, posting old done and dusted news in the hope of protecting his Short position, and playing dirty to try to discredit the company anyone who dares to present contrarian views and facts from the Company rns'. The ONLY way he can entice newbies in is targeting anyone with contrarian views or those posting facts from the company rns'. Wonder why???
hamidahamida
24/3/2020
09:20
New highs now.....
rivaldo
24/3/2020
09:09
They have been struggling for years and partnerships have come and gone..
sikhthetech
24/3/2020
09:07
Arcadian - {#5232}
And why would they "buy them out" ?

- they have taken what they need without getting dragged under
- Byotrol has been consistently struggling for sales to break even

AIMHO

piedro
24/3/2020
09:03
Instead of getting their accounts qualified, they've changed auditors...

Very questionable move, isn't it?



The shares were suspended last Sept, weren't they?.



"The Directors have made every effort to resolve this matter to our auditorâ„¢s satisfaction, without success. Whilst it may have been possible eventually to obtain a suitable response, the length of time this may have required was indeterminate, and the Board took the decision that the interests of shareholders were best served by publishing the accounts with the consequential qualified audit opinion but resulting in the lifting in the suspension from trading on AIM. Since the year end we have transferred over £86,000 of the aggregate amount from the bank concerned to another commercial bank and intend to transfer the balance shortly"

sikhthetech
24/3/2020
08:58
Their initial patent was 25yrs ago.
Their IPO 15yrs ago.

Has anybody attempted to buy them, despite the spike in sales due to swine flu or their partnership with Synergy..

NO.

sikhthetech
24/3/2020
08:57
Fair points. Difficult to gauge " an offer you can`t refuse" at the moment.
arcadian
24/3/2020
08:54
I guess from byotrol's point of view there's a correct order to do things in. Difficult for a buyer to pay a multiple of the current share price so if the ultimate goal is sale of the company then manage the dealflow and newsflow to grow the shareprice ahead of any attempt to actually sell the company. For example, the playbook might read something like:

o Establish positive ebitda on a standalone basis to show they can do it by themselves
o Outlicense some non-core technology to show potential from this activity
o Outlicense / partner some core technology (byotrol24) to wow the market
o Sell the company

And it might still be optimal to leave a fair bit of time between steps 3 and 4, so that the market can see the licensing/partnering deals and underlying demand come through in the financials.

1gw
Chat Pages: Latest  355  354  353  352  351  350  349  348  347  346  345  344  Older

Your Recent History

Delayed Upgrade Clock